相关实验视频

Updated: Jul 18, 2025

Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods

Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods

Published on: September 10, 2018

比较两周一次单剂量阿克丁诺米辛D与低风险妊娠 trofhoblastic 瘤 (FIGO 评分0-4) 的多日甲状腺治疗:研究协议为前性,多中心,随机试验试验

Fang Jiang¹, Ming-Yi Mao¹, Yang Xiang²

¹Department of Obstetrics & Gynaecology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Science, National Clinical Research Center for Obstetric & Gynaecologic Diseases, No. 1 Shuaifuyuan Wangfujing Dongcheng District, Beijing, 100730, China.

|August 23, 2023

概括

这项研究比较了两种化学疗法方案,用于低风险的妊娠 trofhoblastic 瘤. 它旨在确定最有效的单剂治疗方法,指导临床决策以获得更好的患者结果.

科学领域:

妇科妇科妇科妇科
在瘤学瘤学.
药理学药理学是指药理学的学科.

背景情况:

低风险的妊娠 trofhoblastic 瘤 (GTN) 通常用单剂化疗来治疗.
甲托雷克萨特 (MTX) 和阿克丁诺米辛D (Act-D) 是常见的第一线药物,但对治疗方案优越性的证据有限.

研究的目的:

为了比较每两周一次单剂量actinomycin D治疗的疗效和安全性,与低风险GTN的多日甲状腺素治疗相比.
为了指导临床医生选择最佳的单剂化疗方案为GTN患者.

主要方法:

一个多中心,随机,前性临床试验,涉及低风险GTN患者 (FIGO评分0-4).
患者被随机分配1:1接受每两周一次的IV脉冲actinomycin D或多日甲状腺/leucovorin治疗方案.
主要终点:单剂疗法完全缓解率和整体完全缓解率.

主要成果:

这项研究旨在获得两种疗法之间的完全缓解比率和疗效差异.
二级终点包括缓解的持续时间,周期数,不良反应,月经/卵巢功能和生活质量.

结论:

这项试验将提供关键数据,以比较actinomycin D和甲状腺素对低风险GTN的有效性.
这些发现将有助于制定一种优选的治疗指南,用于管理低风险的妊娠 trofhoblastic 瘤.

关键词:

阿克丁诺米 D D 怀孕期的 trofhoblastic 新生病.低风险低风险低风险甲基甲酸二醇的使用方法

更多相关视频

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

In Vitro Assays to Evaluate the Migration, Invasion, and Proliferation of Immortalized Human First-trimester Trophoblast Cell Lines

In Vitro Assays to Evaluate the Migration, Invasion, and Proliferation of Immortalized Human First-trimester Trophoblast Cell Lines

Published on: March 5, 2019

相关概念视频

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...